The shift of expenditure of medical service for diagnosis and treatment of colorectal cancer from 2005 to 2014: a hospital-based retrospective survey in Guangxi

Medical expenditures for CRC diagnosis and treatment in Guangxi during the study period were substantial and increased rapidly, imposing a significant economic burden. The cost structure was heavily dominated by pharmaceutical expenses. The findings underscore the need for policies promoting early detection and efficient resource allocation. This study provides a critical baseline for evaluating the impact of subsequent healthcare reforms and informs future health economic research in Guangxi and similar regions.